08048035968
Reliable Fempro 2.5mg Tablets from India to USA - Philadelphia | Phoenix Exim | Trusted Exporter.

1. General Information

Fempro 2.5 mg Tablet is an oral prescription medicine containing Letrozole 2.5 mg. Letrozole belongs to a class of medicines called aromatase inhibitors. It is primarily prescribed for hormone-sensitive breast cancer in women who have undergone menopause.

This medicine should be used strictly under the supervision of a qualified healthcare professional.

2. Product Information

  • Brand: Fempro
  • Strength: 2.5 mg
  • Active ingredient: Letrozole 2.5 mg
  • Dosage form: Film-coated oral tablet
  • Drug class: Aromatase inhibitor
  • Manufacturer/Marketer: Cipla Ltd.
  • Route: Oral
  • Typical labeled dose: 2.5 mg once daily, although the treating physician determines the appropriate regimen.

3. Uses of Fempro 2.5 mg

Fempro/letrozole is used for certain forms of breast cancer in postmenopausal women, including:

  • Hormone-receptor-positive early breast cancer as adjuvant treatment.
  • Extended adjuvant treatment following previous tamoxifen therapy.
  • Advanced hormone-receptor-positive or hormone-sensitive breast cancer.

Letrozole is also sometimes used for ovulation induction in infertility, but this is a specialist-directed/off-label use in many settings and should not be undertaken without medical supervision.

4. Benefits of Fempro 2.5 mg

Fempro lowers estrogen production in the body. Since some breast cancer cells depend on estrogen for growth, reducing estrogen can help slow or stop the growth of estrogen-dependent cancer cells.

Potential therapeutic benefits include:

  • Helps manage certain hormone-sensitive breast cancers.
  • Can reduce the risk of recurrence when used as appropriate adjuvant therapy.
  • Can be used in the treatment of certain advanced breast cancers.
  • Provides hormonal treatment without directly acting as a conventional cytotoxic chemotherapy drug.

5. Side Effects of Fempro 2.5 mg

Like other prescription medicines, Fempro can cause side effects. They vary from person to person and may depend on treatment duration and individual health.

Possible side effects include:

  • Hot flashes
  • Joint or musculoskeletal pain
  • Increased sweating
  • Fatigue or weakness
  • Headache
  • Dizziness
  • Swelling/edema
  • Bone pain
  • Increased cholesterol
  • Nausea or digestive symptoms

Long-term estrogen reduction can also contribute to loss of bone mineral density and osteoporosis, so monitoring may be recommended by the treating physician.

6. Common Side Effects

The commonly reported adverse reactions include:

  • Hot flashes and flushing
  • Joint pain (arthralgia)
  • Musculoskeletal discomfort
  • Increased sweating
  • Fatigue
  • Headache
  • Dizziness
  • Bone pain
  • Edema
  • Increased cholesterol levels

Seek medical attention promptly for serious symptoms such as severe chest pain, sudden breathing difficulty, signs of a blood clot, severe allergic reactions, or other unusual symptoms.

7. How to Use Fempro 2.5 mg

Take Fempro exactly as prescribed by your doctor.

  • Swallow the tablet whole with water.
  • Do not crush, chew or break it unless your healthcare professional specifically instructs you otherwise.
  • It can generally be taken with or without food.
  • Try to take it at approximately the same time each day.
  • Do not take more tablets than prescribed.
  • Do not stop long-term treatment without discussing it with your doctor.

The standard labeled dose for many breast-cancer indications is 2.5 mg once daily, but individual treatment schedules may differ, particularly in patients with significant liver impairment.

8. How Fempro 2.5 mg Works

Fempro contains letrozole, which blocks the enzyme aromatase. Aromatase is involved in producing estrogen.

By inhibiting aromatase, letrozole reduces estrogen levels. Lower estrogen availability can inhibit the growth of breast cancer cells that depend on estrogen.

9. Safety Advice

  • Pregnancy: Do not use Fempro during pregnancy unless specifically directed by a specialist; letrozole can cause fetal harm.
  • Breastfeeding: Breastfeeding is not recommended during treatment.
  • Menopause: Its approved breast-cancer indications are primarily for postmenopausal women.
  • Bone health: Letrozole can decrease bone mineral density. Your doctor may recommend bone-density monitoring.
  • Cholesterol: Cholesterol levels may increase during treatment, so monitoring may be appropriate.
  • Liver disease: Inform your doctor about liver problems; dose adjustments may be necessary in severe hepatic impairment.
  • Kidney disease: Tell your doctor about significant kidney disease before treatment.
  • Other medicines: Inform your healthcare provider about all medicines, supplements and hormone-containing products you use.
  • Driving: Dizziness, fatigue or sleepiness may occur, so use caution with driving or machinery if affected.
  • Prescription use: Fempro should be obtained and used according to applicable prescription and pharmaceutical regulations.

10. Frequently Asked Questions (FAQs)

Q1. What is Fempro 2.5 mg used for?
Fempro contains letrozole and is primarily used for certain types of breast cancer in postmenopausal women, particularly hormone-receptor-positive disease.

Q2. What is the active ingredient in Fempro?
The active ingredient is Letrozole 2.5 mg.

Q3. How often is Fempro 2.5 mg taken?
The standard labeled dose for many breast-cancer indications is 2.5 mg once daily, but your doctor determines the appropriate treatment schedule.

Q4. Can Fempro be taken with food?
Yes. Letrozole tablets can generally be taken with or without food.

Q5. Can Fempro cause joint pain?
Yes. Joint and musculoskeletal pain are among the commonly reported adverse reactions.

Q6. Can Fempro affect bones?
Yes. Long-term estrogen reduction can decrease bone mineral density, potentially increasing the risk of osteoporosis and fractures. Your doctor may monitor bone health.

Q7. Is Fempro safe during pregnancy?
No. Letrozole can cause fetal harm and should not be used during pregnancy.

Q8. Does Fempro reduce estrogen?
Yes. Letrozole inhibits aromatase and thereby reduces estrogen production.

11. Substitutes for Fempro 2.5 mg

Substitutes should contain the same active ingredient and strength and should only be selected with medical/pharmacist guidance. Examples of letrozole 2.5 mg brands reported as substitutes include:

  • Caditraz 2.5 mg
  • Herhope 2.5 mg
  • Letall 2.5 mg
  • Letov 2.5 mg
  • Stimufol 2.5 mg

Availability and brand names can differ by country, so verify the product, manufacturer, strength and regulatory status before substitution.

12. SEO Keywords

Fempro 2.5 mg Tablets, Fempro 2.5 mg Tablet exporter, Fempro 2.5 mg supplier India, Fempro Letrozole 2.5 mg, Letrozole 2.5 mg Tablets exporter, Fempro 2.5 mg wholesale supplier, Fempro tablets pharmaceutical exporter, Letrozole tablets manufacturer India, Fempro 2.5 mg medicine supplier, breast cancer medicine exporter India, oncology medicine exporter India, hormone therapy medicine supplier, Letrozole 2.5 mg international supplier, Fempro tablets exporter from Nagpur, pharmaceutical exporter Nagpur India, Fempro 2.5 mg export to USA, Fempro 2.5 mg export to UK, Fempro 2.5 mg export to Australia, Fempro 2.5 mg export to Canada, Fempro 2.5 mg export to Singapore, Fempro 2.5 mg export to South Korea, Fempro 2.5 mg export to UAE, genuine Letrozole 2.5 mg supplier, prescription oncology medicine exporter, global pharmaceutical supplier India.

Aug 24th, 2026 2:29 PM

Keywords